GSGregor Scharf

Gregor Scharf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gregor Scharf has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Florian Poschenrieder

    Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany

    2 shared publications
  • Jan Schaible

    Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany

    2 shared publications
  • Benedikt Pregler

    Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany

    1 shared publication
  • Charlotte Knobloch

    Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany

    1 shared publication
  • Christian Stroszczynski

    Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany

    1 shared publication
  • Christian Stroszczynski

    From the Institute of Radiology (Q.D.S., V.M., R.S., S.M., C.S., O.W.H.) and Department of Nuclear Medicine (S.H., D.S., J.G., D.H.), University of Regensburg Medical Center, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; and Departments of Pulmonology (S.B.) and Radiology (O.W.H.), Donaustauf Hospital, Donaustauf, Germany

    1 shared publication

Latest Publications

  • Combined Model of Quantitative Evaluation of Chest Computed Tomography and Laboratory Values for Assessing the Prognosis of Coronavirus Disease 2019

    by Gregor Scharf, Stefanie Meiler, Florian Zeman, Jan Schaible, Florian Poschenrieder, Charlotte Knobloch, Henning Kleine, Sophie Elisabeth Scharf, Julien Dinkel, Christian Stroszczynski, et al.

    Purpose To assess the prognostic power of quantitative analysis of chest CT, laboratory values, and their combination in COVID-19 pneumonia. Materials and Methods Retrospective analysis of patients with PCR-confirmed COVID-19 pneumonia and chest CT performed between March 07 and November 13, 2020. Volume and percentage (PO) of lung opacifications and mean HU of the whole lung were quantified using prototype software. 13 laboratory values were collected. Negative outcome was defined as death, ICU admittance, mechanical ventilation, or extracorporeal membrane oxygenation. Positive outcome was defined as care in the regular ward or discharge. Logistic regression was performed to evaluate the prognostic value of CT parameters and laboratory values. Independent predictors were combined to establish a scoring system for prediction of prognosis. This score was validated on a separate validation cohort. Results 89 patients were included for model development between March 07 and April 27, 2020 (mean age: 60.3 years). 38 patients experienced a negative outcome. In univariate regression analysis, all quantitative CT parameters as well as C-reactive protein (CRP), relative lymphocyte count (RLC), troponin, and LDH were associated with a negative outcome. In a multivariate regression analysis, PO, CRP, and RLC were independent predictors of a negative outcome. Combination of these three values showed a strong predictive value with a C-index of 0.87. A scoring system was established which categorized patients into 4 groups with a risk of 7 %, 30 %, 67 %, or 100 % for a negative outcome. The validation cohort consisted of 28 patients between May 5 and November 13, 2020. A negative outcome occurred in 6 % of patients with a score of 0, 50 % with a score of 1, and 100 % with a score of 2 or 3. Conclusion The combination of PO, CRP, and RLC showed a high predictive value for a negative outcome. A 4-point scoring system based on these findings allows easy risk stratification in the clinical routine and performed exceptionally in the validation cohort. Key Points: Citation Format


  • Radiology of COVID-19 Pneumonia – Pictorial Essay and Structured Reporting

    by Jan Schaible, Stefanie Meiler, Florian Poschenrieder, Gregor Scharf, David Maintz, Benedikt Pregler, Christian Stroszczynski, Okka Wilkea Hamer

    The novel coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)), which originated in China, has caused a worldwide pandemic [1]. The disease caused by SARS-CoV-2 is referred to as Coronavirus Disease 2019 (COVID-19). During the pandemic and probably beyond, radiologists performing CT examinations of patients with symptoms of a respiratory infection will inevitably be asked if it could be a case of COVID-19 pneumonia. On the other hand, if a chest CT performed for another indication yields abnormal results, the radiologist must consider the possibility of incidental COVID-19 pneumonia, communicate this to the referring physician as quickly as possible, and introduce the appropriate hygiene measures in his/her own department.